Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy

被引:44
|
作者
Ray, P [1 ]
Quantin, X [1 ]
Grenier, J [1 ]
Pujol, JL [1 ]
机构
[1] CHU Montpellier, Hop Arnaud de Villeneuve, Serv Malad Resp, F-34295 Montpellier, France
来源
CANCER DETECTION AND PREVENTION | 1998年 / 22卷 / 04期
关键词
chemotherapy; CYFRA; 21-1; cytokeratins; lung cancer; neuron-specific enolase; survival; tissue polypeptide-specific antigen; tumor markers; tumor response;
D O I
10.1046/j.1525-1500.1998.CDOA43.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was (i) to determine predictive factors of a complete response to chemotherapy in small cell lung cancer (SCLC) and predictive factors of an objective response in non-small cell lung cancer (NSCLC) and (ii) to determine whether prognostic factors are different with regard to treatment response and survival. Ninety-nine patients with SCLC and two hundred and two patients with NSCLC received chemotherapy. The following variables were recorded prior to treatment: tumor, node, metastasis status, performance status, body weight loss, blood leukocyte count, serum sodium, serum albumin, lactate dehydrogenase (LDH), alkaline phosphatase, serum NSE, serum TPS, and serum CYFRA 21-1. Tumor response was analyzed at the 10th week. Analysis of survival were done using the landmark method. Hazard ratios of the significant prognostic variables of survival were calculated using the Cox's model. Odds ratios of the significant predicting factors of response were calculated by stepwise logistic regression. In SCLC, the significant determinants of poor survival were: lack of complete response (HR: 2.04), weight loss (HR: 1.76), high serum LDH level (HR: 1.64), and high serum TPS level (HR: 2.47). A high serum TPS level was the only factor among those studied able to predict lack of achievement of complete response (OR: 0.39). In NSCLC, significant determinants of poor survival were: no objective response (HR: 2.28), poor performance status (HR: 2.52), presence of metastases (HR: 1.51), and high serum CYFRA 21-1 level (HR: 1.84). On the other hand, a high serum TPS level (OR: 0.50), the presence of metastases (OR: 0.45), and a leukocyte blood count over 10,000/mu l (OR: 0.43) were independent determinants for a patient not to achieve an objective response. We concluded that the predictive factors of complete response in SCLC remain to be defined. On the other hand, in NSCLC three variables contribute to the prediction of an objective response. Finally, determinants of survival differ from predictive factors of response.
引用
收藏
页码:293 / 304
页数:12
相关论文
共 50 条
  • [31] Tumor markers as prognostic factors in treated non-small cell lung cancer
    Trapé, J
    Buxo, J
    De Olaguer, JP
    Vidal, C
    ANTICANCER RESEARCH, 2003, 23 (5B) : 4277 - 4281
  • [32] Clinicopathological factors related to survival in lung cancer
    Kefeli, Umut
    Oven Ustaalioglu, Bala Basak
    Yildirim, Mahmut Emre
    Erkol, Burcak
    Aydin, Dincer
    Sener, Nur
    Sonkaya, Alper
    Acikgoz, Ozgur
    MARMARA MEDICAL JOURNAL, 2015, 28 (01): : 21 - 26
  • [33] Factors affecting survival in patients with lung cancer
    Esmaeel, Hend M.
    Atta, Kamal A.
    Nabil, Emad E.
    Naom, Mariam A.
    Ali, Abdellah H.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2021, 70 (02): : 242 - 248
  • [34] Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients
    Hong, Soojung
    Cho, Byoung Chul
    Choi, Hye Jin
    Jung, Minkyu
    Lee, Soo Hyeon
    Park, Kyung Soo
    Kim, Se Kyu
    Kim, Joo Hang
    ONCOLOGY, 2010, 79 (3-4) : 293 - 300
  • [35] PREDICTIVE FACTORS OF TUMOR RESPONSE AFTER NEOADJUVANT CHEMORADIATION FOR LOCALLY ADVANCED RECTAL CANCER
    Moureau-Zabotto, Laurence
    Farnault, Bertrand
    de Chaisemartin, Cecile
    Esterni, Benjamin
    Lelong, Bernard
    Viret, Frederic
    Giovannini, Marc
    Monges, Genevieve
    Delpero, Jean-Robert
    Bories, Erwan
    Turrini, Olivier
    Viens, Patrice
    Salem, Naji
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02): : 483 - 491
  • [36] Pronostic and predictive factors in lung cancer
    Marijon, H.
    Bouyon, A.
    Vignot, S.
    Besse, B.
    BULLETIN DU CANCER, 2009, 96 (04) : 391 - 404
  • [37] Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma
    Erdogan, Furkan
    Cinka, Hikmet
    Akman, Bahattin Cagdas
    Coskun, Huseyin Sina
    Dabak, Nevzat
    JOINT DISEASES AND RELATED SURGERY, 2023, 34 (01): : 196 - 206
  • [38] SERUM-ALBUMIN AND OTHER PROGNOSTIC FACTORS RELATED TO RESPONSE AND SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
    ESPINOSA, E
    FELIU, J
    ZAMORA, P
    BARON, MG
    SANCHEZ, JJ
    ORDONEZ, A
    ESPINOSA, J
    LUNG CANCER, 1995, 12 (1-2) : 67 - 76
  • [39] MRI Predictive Factors for Tumor Response in Rectal Cancer Following Neoadjuvant Chemoradiation Therapy - Implications for Induction Chemotherapy?
    Yu, Stanley K. T.
    Tait, Diana
    Chau, Ian
    Brown, Gina
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (03): : 505 - 511
  • [40] Factors predictive of survival after lobectomy for non-small cell lung cancer in Iceland during 1999-2008
    Oskarsdottir, Guorun Nina
    Skuladottir, Rut
    Isaksson, Helgi J.
    Jonsson, Steinn
    Porsteinsson, Hunbogi
    Guobjartsson, Tomas
    LAEKNABLADID, 2010, 96 (04): : 251 - 257